Literature DB >> 1683955

Catamenial epilepsy and goserelin.

Y Haider, D B Barnett.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1683955     DOI： 10.1016/0140-6736(91)92354-5

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  7 in total

1.  Progesterone vs placebo therapy for women with epilepsy: A randomized clinical trial.

Authors:  A G Herzog; K M Fowler; S D Smithson; L A Kalayjian; C N Heck; M R Sperling; J D Liporace; C L Harden; B A Dworetzky; P B Pennell; J M Massaro
Journal:  Neurology       Date:  2012-05-30       Impact factor: 9.910

Review 2.  Treatments for seizures in catamenial (menstrual-related) epilepsy.

Authors:  Melissa J Maguire; Sarah J Nevitt
Journal:  Cochrane Database Syst Rev       Date:  2019-10-14

Review 3.  Hormonal therapy for epilepsy.

Authors:  Scott J Stevens; Cynthia L Harden
Journal:  Curr Neurol Neurosci Rep       Date:  2011-08       Impact factor: 5.081

Review 4.  Treatments for seizures in catamenial (menstrual-related) epilepsy.

Authors:  Melissa J Maguire; Sarah J Nevitt
Journal:  Cochrane Database Syst Rev       Date:  2021-09-16

Review 5.  The role of neurosteroids in the pathophysiology and treatment of catamenial epilepsy.

Authors:  Doodipala Samba Reddy
Journal:  Epilepsy Res       Date:  2009-04-29       Impact factor: 3.045

6.  Hormonal therapies: progesterone.

Authors:  Andrew G Herzog
Journal:  Neurotherapeutics       Date:  2009-04       Impact factor: 7.620

Review 7.  A Clinical Approach to Catamenial Epilepsy: A Review.

Authors:  Samuel Frank; Nichole A Tyson
Journal:  Perm J       Date:  2020-12
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.